SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-091837
Filing Date
2024-08-06
Accepted
2024-08-06 16:15:25
Documents
50
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rlay-20240630.htm   iXBRL 10-Q 1972919
2 EX-31.1 rlay-ex31_1.htm EX-31.1 16210
3 EX-31.2 rlay-ex31_2.htm EX-31.2 16038
4 EX-32.1 rlay-ex32_1.htm EX-32.1 13536
  Complete submission text file 0000950170-24-091837.txt   7056293

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rlay-20240630.xsd EX-101.SCH 1089847
52 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20240630_htm.xml XML 1110609
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39385 | Film No.: 241179456
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)